Cervarix offers HPV protection past 6 years, study shows

12/3/2009 | Yahoo!

A study that included almost 800 young women ages 15 to 25 found the new vaccine Cervarix offered protection against the human papillomavirus virus for longer than six years. Vaccine efficacy remained at 100% against 12-month persistent infection with HPV-16/18, the data showed.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN